Latest Keytruda News and Updates : Keytruda updates, Keytruda News , Keytruda around the world

Nishadil

Washington | 19°C (scattered clouds)

Merck's Bold Bet Beyond Keytruda: Forging a Future of Pharmaceutical Innovation

Top story

Merck's Bold Bet Beyond Keytruda: Forging a Future of Pharmaceutical Innovation

In focus

Latest feed

Merck's Master Plan: Building a Multi-Billion Dollar Future Beyond Keytruda

Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur

Merck's Bold Bet: A Deep Dive into the Pipeline Powering Post-Keytruda Growth

The Unbearable Price of Hope

Latest headlines

Seeing Beyond the Headlines: Why This Investor Stays Bullish on Merck

Seeing Beyond the Headlines: Why This Investor Stays Bullish on Merck

A Tale of Two Pharma Giants: Wolfe Research Shifts Gears on Merck and AbbVie

A Tale of Two Pharma Giants: Wolfe Research Shifts Gears on Merck and AbbVie

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

Cramer's 2025 Check-Up: Is Merck Still a Buy?

Cramer's 2025 Check-Up: Is Merck Still a Buy?

A New Horizon for Bladder Cancer Patients: FDA Approves Keytruda-Padcev Combo as First-Line Therapy

A New Horizon for Bladder Cancer Patients: FDA Approves Keytruda-Padcev Combo as First-Line Therapy

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

A Setback on the Cancer Front: The Unfolding Story of Keytruda and Lenvima

A Setback on the Cancer Front: The Unfolding Story of Keytruda and Lenvima

Beyond the Pandemic: Moderna's Ambitious Bet on mRNA as the Next Big Cancer Weapon

Beyond the Pandemic: Moderna's Ambitious Bet on mRNA as the Next Big Cancer Weapon

A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk

A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk

The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care

The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care

The Dawn of Personalized Cancer Vaccines: A Glimmer of Hope in the Fight Against Melanoma

The Dawn of Personalized Cancer Vaccines: A Glimmer of Hope in the Fight Against Melanoma

Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny

Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny

A New Horizon in Lung Cancer Treatment: FDA Grants Breakthrough Status to Lilly-Merck Combination Therapy

A New Horizon in Lung Cancer Treatment: FDA Grants Breakthrough Status to Lilly-Merck Combination Therapy

Load more